Latest news:

Presentation of Follicum at LSX Nordic Congress 30 August 2018

Follicum’s CEO Jan Alenfall presented the company at LSX Nordic Congress in Stockholm 30 August 2018. See the presentation For further information, please contact: Jan Alenfall – CEO, Follicum AB Telephone: +46 (0)46 – 19 21 97 Email: info@follicum.com About Follicum AB Follicum is a biotech company focused on the discovery and development of peptide-based […]

Sign up for our Newsletter

Hair growth

Our drug candidate FOL-005 has, in clinical trials, demonstrated increased hair growth on healthy individuals

Read more

Diabetes

Follicums pre-clinical research has resulted in a new peptide class which increased the release of insulin on mice

Read more

Investors

We want to develop safe, effective and cost effective drugs, suitable for both men and women, that have minimal side effects

Read more

Press

News

Events

05 Nov 18
BIO Europe

Follicum will attend the BIO Europe Conference 5-7 November 2018 in Copenhagen, Denmark More informa...